Jennifer S. Temel, clinical director, Thoracic Oncology, Massachusetts General Hospital, discusses a phase III study that examined the impact of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia.
Videos
Metastatic Prostate Cancer
Metastatic Prostate Cancer
Unresectable Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
2
Tucatinib: Chemo-Sparing Maintenance for HER2+ Metastatic Breast Cancer
3
High Survival Seen with Nogapendekin Alfa Inbakicept in Papillary NMIBC
4
Illuminating the Sequence of Third-Line Therapies in Metastatic CRC
5